8.0 bibliography - shodhgangashodhganga.inflibnet.ac.in/.../14/14_bibliography.pdf · davis jm...
TRANSCRIPT
235
8.0 Bibliography
236
A
Anagnostou A, Lee ES, Kessimian N, Levinson R and Steiner M (1990). Erythropoietin
has a mitogenic and positive chemo tactic effect on endothelial cells. Proceedings of
National Academy of Sciences (USA), 87: 5978-5982.
Angell M (2005). The truth about the drug companies: How they deceive us and what to
do about it. Random House Trade Paperbacks (New York), p60.
Asgar E (1992). Can milk replace serum in mammalian cell culture. Cytotechnology, 8:
1-4.
B
Balk SD, Levine SP, Young L, La Fleur MM and Raymond NM (1981). Mitogenic
factors present in serum but not in plasma. Proceedings of National Academy of Sciences
(USA), 78: 5656-5660.
Balls M, Goldberg AM, Fentem JH, Broadhead CL, Burch RL, Festing MF, Frazier
JM, Hendriksen CF, Jennings M, Vander Kamp MD, Morton DB, Rowan AN, Russell
C, Russell WM, Spielmann H, Stephens ML, Stokes WS, Straughan DW, Yager
JD, Zurlo J and Van Zutphen BF (1995). The three Rs: the way forward. The report and
recommendations of ECVAM workshop 11. Alternatives to Laboratory Animals, 23:
838-866.
Batista FRX, Pereira CA, Mendonca RZ and Moraes AM (2005). Enhancement of Sf9
cells and baculovirus production employing Grace's medium supplemented with milk
whey ultrafiltrate. Cytotechnology, 49: 1-9.
Batista FRX, Pereira CA, Mendonça RZ and Moraes AM (2006). Evaluation of
concentrated milk whey as a supplement for SF9 Spodoptera frugiperda cells in culture.
Electronic Journal of Biotechnology, 9: 32-35.
237
Becerra SP and Amaral J (2002). Erythropoietin-an endogenous retinal survival factor.
The New England Journal of Medicine, 347: 1968-1970.
Belford DA, Rogers ML, Regester GO, Francis GL, Smithers GW, Liepe IJ, Priebe IK
and Ballard FJ (1995). Milk-derived growth factors as serum supplements for the growth
of fibroblasts and epithelial cells. In Vitro Cellular and Developmental Biology, 31: 752-
760.
Bernaudin M, Bellail A, Marti HH, Yvon A, Vivien D, Duchatelle I, Mackenzie ET and
Petit E (2000). Neurons and astrocytes express EPO mRNA: Oxygen-sensing
mechanisms that involve the redox-state of the brain. Glia, 30: 271-278.
Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET and Petit E
(1999). A potential role for erythropoietin in focal permanent cerebral ischemia in mice.
Journal of Cerebral Blood Flow and Metabolism, 19: 643-651.
Bianco P and Robey PG (2001). Stem cells in tissue engineering. Nature, 414: 118-121.
Bieber E (2001). Erythropoietin, the biology of erythropoiesis and epoetin alfa. An
overview. Journal of Reproductive Medicine, 46: 521-530.
Birch JR and Arathoon R (1990). Suspension culture of mammalian cells. Bioprocess
Technology, 10: 251-270.
Birch JR and Froud SJ (1994). Mammalian cell culture systems for recombinant protein
production. Biologicals, 22: 127-133.
Bjare U (1992). Serum-free cell culture. Pharmacology and Therapeutics, 53: 355-374.
Borellini F and Glazer RI (1993). Induction of Sp1-p53 DNA-binding heterocomplexes
during granulocyte/macrophage colony-stimulating factor-dependent proliferation in
human erythroleukemia cell line TF-1. Journal of Biological Chemistry, 268: 7923-7928.
Breitling R, Klingner S, Callewaert N, Pietrucha R, Geyer A, Ehrlich G, Hartung R,
Muller A, Contreras R, Beverley SM and Alexandrov K (2002). Non-pathogenic
trypanosomatid protozoa as a platform for protein research and production. Protein
Expression and Purification, 2: 209-218.
238
Buemi M, Caccamo C and Nostro L (2005). Brain and cancer: the protective role of
erythropoietin. Medical Care Research and Review, 25: 245-259.
Bury D, Jelen P and Kimura K (1998). Whey protein concentrate as a nutrient
supplement for lactic acid bacteria. International Dairy Journal, 8: 149-151.
C
Campbell PJ (1974). The second International standard for recombinant erythropoietin.
Journal of Biological Standardization, 2: 259-267.
Carpenter G and Cohen S (1979). Epidermal growth factor. The Annual Review of
Biochemistry, 48: 193-216.
Casadevall N, Mayeux P and Lacombe C (1989). Erythropoietin physiology dosage and
pathology. Immuno-Biological Analysis and Specialized, 4: 7-12.
Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC and Schumacker PT
(1998). Mitochondrial reactive oxygen species trigger hypoxia induced transcription.
Proceedings of National Academy of Sciences (USA), 95: 11715-11720.
Chapelle ADL, Traskelin AL and Juvonen E (1993). Truncated erythropoietin receptor
causes dominantly inherited benign human erythrocytosis. Proceedings of National
Academy of Sciences (USA), 90: 4495-4499.
Cohen S (1987). Epidermal growth factor. In Vitro Cellular and Developmental Biology,
23: 239-246.
Coleman T and Brines M (2004). Recombinant human erythropoietin in critical illness: a
role beyond anaemia. Critical Care, 8: 337-341.
Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S, An R, Bowers PJ,
Burton P, Klausner MA and Corwin MJ (2007). Efficacy and safety of epoetin alfa in
critically ill patients. The New England Journal of Medicine, 357: 965-976.
Crespi CL and Thilly WG (1981). Continuous cell propagation using low-charge
microcarriers. Biotechnology and Bioengineering, 23: 983-993.
239
Czyz J, Wiese C, Rolletschek A, Blyszczuk P, Cross M and Wobus AM (2003). Potential
of embryonic and adult stem cells in vitro. Biological Chemistry, 384: 1391-1409.
D
Davis JM (2002). Basic Cell Culture: A Practical Approach, 2nd
Ed. Oxford University
Press (New York), p25-105.
Davis D, Charles PJ, Potter A, Feldmann M, Maini RN and Elliott MJ (1997). Anaemia
of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha
blockade. British Journal of Rheumatology, 36: 950-956.
Deacon R, Hellebostad M, Gaines Das RE, Milne A, Rowley M and Cotes MP (1993).
Invalidity from non-parallelism in a radioimmunoassay for erythropoietin accounted for
by human serum antibodies to rabbit IgG. Experimental Haematology, 21: 1680-1685.
Denhart DT (1996). Signal-transducing protein phosphorylation cascades mediated by
Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling.
Biochemical Journal, 318: 729-747.
Deuel TF (1987). Polypeptide growth factors: roles in normal and abnormal cell growth.
Annual Review of Cell and Developmental Biology, 3: 443-492.
Dormont D (1999). Transmissible spongiform encephalopathy agents and animal sera.
Developments in Biological Standardization, 99: 25-34.
E
Ehrenreich H, Degner D and Meller J (2004). Erythropoietin: a candidate compound for
neuroprotection in schizophrenia. Molecular Psychiatry, 9: 42–54.
Eliot M (1999). Risks of virus transmission associated with animal sera or substitutes
and methods of control. Developments in Biological Standardization, 99: 9-16.
Eridani S, Sgaramella V and Cova L (2004). Stem cells: from embryology to cellular
therapy? An appraisal of the present state of the art. Cytotechnology, 44: 125-141.
240
Erslev AJ (1953). Humoral Regulation of Red Cell Production. Blood, 8: 349-357.
Eschbach JW, Egrie JC, Downing MR, Browne JK and Adamson JW (1987). Correction
of the anemia of end-stage renal disease with recombinant human erythropoietin: Results
of a combined phase I and II clinical trial. New England Journal of Medicine, 316: 73-
78.
European Pharmacopoeia (2008). Monograph of erythropoietin concentrated solution, 6th
Ed. Council of Europe (France), p1813-1817.
Even MS, Sandusky CB and Barnard ND (2006). Serum free hybridoma culture: ethical,
scientific and safety considerations. Trends in Biotechnology, 24: 105-108.
F
6.1 Fandrey J, Frede S, Ehleben W, Porwol T, Acker H and Jelkmann W
(1997). Cobalt chloride and desferrioxamine antagonize the inhibition of
erythropoietin production by reactive oxygen species. Kidney International,
51: 492-496.
Fassolitis AC, Novelli RM and Larkin EP (1981). Serum substitute in epithelial cell
culture media: nonfat dry milk filtrate. Applied Environmental Microbiology, 42: 200-
203.
Filipic B, Shehata M, Toth S, Schwarzmeier J and Koren S (2002). Novel serum
replacement based on bovine ocular fluid: a useful tool for cultivation of different animal
cells in vitro. Alternatives to Laboratory Animals, 19: 15-20.
Fisher JW (2003). Erythropoietin: physiology and pharmacology update. Experimental
Biology and Medicine, 228:1-14.
Fraser MJ (1992). The baculovirus-infected insect cell as a eukaryotic gene expression
system. Current Topics in Microbiology and Immunology, 158: 131-172.
241
Fraser JK, Tan AS, Lin FK and Berridge MV (1989). Expression of specific high-affinity
binding sites for erythropoietin on rat and mouse megakaryocytes. Experimental
Hematology, 17: 10-16.
Freshney RI (2005). Culture of animal cells: A manual of basic technique, 5th
Ed. Wiley
Liss (New York), p25-51.
Froud SJ (1999). The development, benefits and disadvantages of serum free media.
Developments in Biological Standardization, 99: 157-166.
G
Genc S, Koroglu TF and Genc K (2004). Erythropoietin and the nervous system. Brain
Research, 1000: 19-31.
Giard DJ, Thilly WG, Wang DI and Levine DW (1977). Virus production with a newly
developed microcarrier system. Applied Environmental Microbiology, 34: 668–672.
Glazer V (2001). Current trends and innovations in cell culture. Genetic Engineering, 21:
11-16.
Gochenour AM and Baron S (1959). Viral sensitivity of cell cultures maintained with
skim milk medium. Proceedings of the Society for Experimental Biology and medicine,
102: 230-233.
Goldwasser E and Sherwood JB (1981). Annotation, radioimmunoassay of
erythropoietin. British Journal of Haematology, 48: 559-563.
Gospodarowicz D, Ferrara N, Schweigerer L and Neufeld G (1987). Structural
characterization and biological functions of fibroblast growth factor. Endocrine Reviews,
8: 95-114.
Gospodarowicz D and Ill CR (1980). Do plasma and serum have different abilities to
promote cell growth?. Proceedings of National Academy of Sciences (USA), 77: 2726-
2730.
242
Grammel N, Dittrich F, Kandzia S, Grabenhorst E and Harald SC (2010). Biosimilarity
of recombinant human EPO products from CHO cell lines: A carbohydrate structural
view. Cells and Culture, 4: 861-865.
Griffiths B, Thornton B and McEntee I (1980). Production of herpes viruses in
microcarrier cultures of human diploid and primary chick fibroblast cells. European
Journal of Cell Biology, 22: 606.
Gstraunthaler G (2003). Alternatives to the use of fetal bovine serum: serum-free cell
culture. Alternatives to Laboratory Animals, 20: 275-281.
Gunga HC, Kirsch KA, Roecker L, Kohlberg E, Tiedemann J, Steinach M and
Schobersberger W (2007). Oxygen transport at high altitude: An integrated
perspective erythropoietin regulations in humans under different environmental and
experimental conditions. Respiratory Physiology and Neurobiology, 158: 287-297.
H
Hacker LD, Jesus MD and Wurm FM (2009). Twenty five years of recombinant proteins
from reactor-grown cells-where do we go from here?. Biotechnology Advances, 27:
1023-1027.
Hammerling U, Kroon R, Wilhelmsen T and Sjodin L (1996). In vitro bioassay for
human erythropoietin based on proliferative stimulation of an erythroid cell line and
analysis of carbohydrate-dependent microheterogeneity. Journal of Pharmaceutical and
Biomedical Analysis, 14: 1455-1469.
Haroon ZA, Amin K, Jiang X and Arcasoy MO (2003). A novel role for erythropoietin
during fibrin-induced wound-healing response. American Journal of Pathology. 163:
993-1000.
Hartung T (2002). Good cell culture practice task force report 1, American Theological
Library Association, 30: 407-414.
Hartung T (2007). Food for thought on cell culture. Alternatives to Laboratory Animals,
24: 143-147.
243
Heldin CH, Wasteson A and Westermark B (1985). Platelet derived growth factor.
Molecular and Cellular Endocrinology, 39: 169-187.
Hill CS and Treisman R (1995). Transcriptional regulation by extracellular signals:
mechansims and specificity. Cell, 80: 199-211.
Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K,
Pyun KH and Kishimoto T (1989). Purification to homogeneity and characterization of
human B-cell differentiation factor (BCDF or BSFp-2). Proceedings of National
Academy of Sciences (USA), 82: 5490-5494.
Hitomi K, Fujita K, Sasaki R, Chiba H, Okuno Y, Ichiba S, Takahashi T and Imura H
(1988). Erythropoietin receptor of a human leukemic cell line with erythroid
characteristics. Biochemical and Biophysical Research Communications, 154: 902-909.
I
7.0 Ihle JN (1995). Cytokine receptor signalling. Nature, 377: 591-594.
Inoue N, Takeuchi M and Ohashi H (1995). The production of recombinant human
erythropoietin. Biotechnology Annual Review, 1: 297-313.
J
Jacobson LO, Goldwasser E, Fried W and Plzak L (1957). Role of the kidney in
erythropoiesis. Nature, 179: 633-634.
Jarvis DL (1991). Baculovirus expression vectors: A review and update. Annals of the
New York Academy of Sciences, 646: 240-247.
Jayme DW, Epstein DA and Conrad DR (1988). Fetal bovine serum alternatives. Nature,
334: 547-548.
Jelkmann W (1986). Renal erythropoietin: properties and production. Review of
Physiology Biochemistry and Pharmacology, 104: 139-215.
Jelkmann W (1992). Erythropoietin: Structure, control of production and function.
Physiology Review, 72: 449-489.
244
Jelkmann W (1994). Biology of erythropoietin. Journal of Clinical Investigation, 72: 3-
10.
Jelkmann W (2007). Erythropoietin after a century of research: younger than ever.
European Journal of Haematology, 78: 183-205.
Joachim F (2004). Oxygen-dependent and tissue-specific regulation of erythropoietin
gene expression. American Journal of Physiology Regulatory Integrative Comparative
Physiology, 286: 977-988.
Jochems CEA, Vander Valk JBF, Stafleu FR and Baumans V (2002). The use of fetal
bovine serum: ethical or scientific problem?. Alternatives to Laboratory Animals, 30:
219-227.
Jordan M, Schallhorn A and Wurn FM (1996). Transfecting mammalian cells:
optimization of critical parameters affecting calcium-phosphate precipitate formation.
Nucleic Acids Research, 24: 596-601.
Juul S (2004). Recombinant erythropoietin as a neuroprotective treatment: in vitro and in
vivo models. Clinics in Perinatology, 31: 129-142.
Juul SE, Anderson DK, Li Y and Christensen RD (1998). Erythropoietin and
erythropoietin receptor in the developing human central nervous system. Pediatric
Research, 43: 40-49.
K
Kathelyn SS and Michael K (1981). Serum-free growth of normal and transformed
fibroblasts in milk: differential requirements for fibronectin. Journal of Cell Biology, 88:
294-300.
Kathelyn SS, Robert P, David H and Michael K (1981). The serum-free growth of
cultured cells in bovine colostrum and in milk obtained later in the lactation period.
Journal of Cellular Physiology, 109: 223-234.
245
Kazal LA and Erslev AJ (1975). The measurement of erythropoietin. Annals of Clinical
and Laboratory Science, 5: 91-97.
Kenneth M, Zhao ZC, Faqi L and Yan CS (2008). Erythropoietin: elucidating new
cellular targets that broaden therapeutic strategies. Progress in Neurobiology,
85: 194-213.
Kitamura A, Tojo T, Kuwaki S, Chiba K, Miyazono A, Urabe A and Takaku F (1989).
Identification and analysis of human erythropoietin receptors on a factor-dependent cell
line, TF-1. Blood, 73: 375-380.
Kitamura A, Tojo T, Kuwaki S, Chiba K, Miyazono A, Urabe A and
Takaku F (1991). IL-1 up-regulates the expression of cytokine receptors on a factor-
dependent human hemopoietic cell line, TF-1. International Immunology, 3: 571-577.
Kitamura A, Tojo T, Kuwaki S, Chiba K, Miyazono A, Urabe A and Takaku F (2005).
Establishment and characterization of a unique human cell line that proliferates
dependently on GM-CSF, IL-3, or erythropoietin. Journal of Cellular Physiology, 140:
323-334.
Klagsbrun M (1980). Bovine colostrum supports the serum free proliferation of epithelial
cells but not of fibroblasts in long-term culture. Journal of Cell Biology, 84: 808-814.
Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M and
Bataille R (1989). Paracrine rather than autocrine regulation of myeloma-cell growth and
differentiation by interleukin-6. Blood, 73: 517-526.
Klingmuller U, Hong Wu, Hsiao JG, Toker A, Duckworth BC, Cantley LC and Lodish
HF (1997). Identification of a novel pathway important for proliferation and
differentiation of primary erythroid progenitors. Proceedings of National Academy of
Sciences (USA), 94: 3016-3021.
Kohler M, Ayotte C, Desharnais P, Flenker U, Ludke S, Thevis M, Volker-Schanzer E
and Schanzer W (2008). Discrimination of recombinant and endogenous urinary
erythropoietin by calculating relative mobility values from SDS gels. International
Journal of Sports Medicine, 29: 1-6.
246
8.0 Konishi Y, Chui DH, Hirose H, Kunishita T and Tabira T (1993). Trophic effect
of erythropoietin and other hematopoietic factors on central cholinergic neurons in
vitro and in vivo. Brain Research, 609: 29-35.
Kost TA and Condreay JP (1999). Recombinant baculoviruses as expression vectors for
insect and mammalian cells. Current Opinion in Biotechnology, 10: 428-433.
Kost TA and Condreay JP (2002). Recombinant baculoviruses as mammalian cell gene-
delivery vectors. Trends in Biotechnology, 20: 173-180.
Kost TA, Condreay JP and Jarvis DL (2005). Baculovirus as versatile vectors for protein
expression in insect and mammalian cells. Nature Biotechnology, 23: 567-575.
Krantz SB (1991). Erythropoietin. Blood, 77: 419 434.
Kyriakis JM and Avruch J (2001). Mammalian mitogen-activated protein kinase signal
transduction pathways activated by stress and inflammation. Physiological Reviews, 81:
807-869.
L
Lai PH, Everett R and Wang FF (1986). Structural characterization of human
erythropoietin. Journal of Biological Chemistry, 261: 3116-3121.
Lappin TRJ, Elder GE, Taylor T, McMullin MF and Bridges JM (1988). Comparison of
the mouse spleen cell assay and a radioimmunoassay for the measurement of serum
erythropoietin. British Journal of Haematology, 70: 117-120.
Lasne F, Martin L, Crepin N and Ceaurriz DJ (2002). Detection of isoelectric profiles of
erythropoietin in urine: differentiation of natural and administered recombinant
hormones. Analytical Biochemistry, 311: 119-126.
Lee HS (1984). Cloning and expression of human erythropoietin cDNA in Escherichia
coli. Proceedings of National Academy of Sciences (USA), 81: 2708-2712.
247
Lee GM, Kim EJ, Kim NS, Yoon SK, Ahn YH and Song JY (1999). Development of a
serum-free medium for the production of erythropoietin by suspension culture of
recombinant chinese hamster ovary cells using a statistical design. Journal of
Biotechnology, 69: 85-93.
Levi-Montalcini R (1987). The nerve growth factor: thirty-five years later. The European
Molecular Biology Organization Journal, 6: 1145-1154.
Lewczuk P, Hasselblatt M, Kamrowski-Kruck H, Heyer A, Unzicker C, Siren AL and
Ehrenreich H (2000). Survival of hippocampal neurons in culture upon hypoxia: effect of
erythropoietin. Neuro Report, 11: 3485-3488.
8.1 Lindl T and Gstraunthaler G (2008). Cell and tissue culture: from the basics
to the bench, 6th Ed. Spectrum Akademischer Verlag (Heidelberg), p110-
115.
Lin FK, Suggs S, Lin CH, Browne JK, Smalling R, Egrie JC, Chen KK, Fox GM, Martin
F and Stabinsky Z (1985). Cloning and expression of the human erythropoietin gene.
Proceedings of National Academy of Sciences (USA), 82: 7580-7584.
M
Macdougall IC, Tucker B, Thompson J, Tomson CR, Baker LR and Raine AE (1996). A
randomized controlled study of iron supplementation in patients treated with
erythropoietin. Kidney International, 50: 1694-1699.
Mark JK (2005). Erythropoietin: the story of hypoxia and a finely regulated
hematopoietic hormone. Experimental Hematology, 33: 1263-1270.
Marti HH, Gassmann M, Wenger RH, Kvietikova I, Morganti-Kossmann MC,
Kossmann T, Trentz O and Bauer C (1997). Detection of erythropoietin in human liquor:
intrinsic erythropoietin production in the brain. Kidney International, 51: 416-418.
Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, Yonekawa
Y, Bauer C and Gassmann M (1996). Erythropoietin gene expression in human, monkey
and murine brain. European Journal of Neuroscience, 8: 666-676.
248
Masaomi N and Kai-Uwe E (2006). The kidney and anemia pathogenesis of renal
anemia. Seminars in Nephrology, 26: 261-268.
Masters JRW (2000). Animal cell culture: A practical approach, 3rd
Ed. Oxford
University Press (New York), p53-66.
Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M and Sasaki R (1994). A novel site
of erythropoietin production: oxygen-dependent production in cultured rat astrocytes.
Journal of Biological Chemistry, 269: 19488-19493.
McCarroll L and King LA (1997). Stable insect cell cultures for recombinant protein
production. Current Opinion in Biotechnology, 8: 590-594.
McKeehan WL, Barnes D, Reid L, Stanbridge E, Murakami H, Sato GH and Alton JW
(1990). Frontiers in mammalian cell culture. In Vitro Cellular and Developmental
Biology, 26: 9-23.
Meignier B (1979). Cell culture on beads used for the industrial production of foot-and-
mouth disease virus. Developments in Biological Standardization, 42: 141-145.
Meignier B, Mougeot H and Favre H (1980). Foot and mouth disease virus production
on microcarrier-grown cells. Developments in Biological Standardization, 46: 249-256.
Meistrell ME, Botchkina GI, Wang H, Di Santo E, Cockroft KM, Bloom O,
Vishnubhakat JM, Ghezzi P and Tracey KJ (1997). Tumor necrosis factor is a brain
damaging cytokine in cerebral ischemia. Shock, 8: 341-348.
Mered B, Albrecht P and Hopps HE (1980). Cell growth optimization in microcarrier
culture. In Vitro Cellular and Developmental Biology, 16: 859-865.
Michel YD (2007), Laminin provides a better substrate than fibronectin for attachment,
growth, and differentiation of 1003 embryonal carcinoma cells. In vitro Cellular and
Developmental Biology, 18: 997-1003.
249
Middleton SA, Barbone FP, Johnson DL, Thurmond RL, You Y, McMahon FJ, Jin R,
Livnah O, Tullai J, Farrell FX, Goldsmith MA, Wilson IA and Jolliffe LK (1999).
Shared and unique determinants of the erythropoietin (EPO) receptor are important for
binding EPO and EPO mimetic peptide. Journal of Biological Chemistry, 274: 14163-
14169.
Milano M and Schneider M (2007). EPO in cancer anemia: Benefits and potential risks.
Critical Reviews in Oncology/Hematology, 62: 119-125.
Miller ME, Garcia JF, Cohen RA, Cronkite EP, Moccia G and Acevedo J (1981).
Diurnal levels of immunoreactive erythropoietin in normal subjects and subjects with
chronic lung disease. British Journal of Haematology, 49: 189-200.
Minuth WW, Sittinger M and Kloth S (1998). Tissue engineering: generation of
differentiated artificial tissues for biomedical applications. Cell and Tissue Research,
291: 1-11.
Miyazaki H, Kozutsumi H, Kato T, Hoshi S, Tamura S, Kubota M and Suzuki T (1988).
Production of monoclonal antibodies against human erythropoietin and their use in the
purification of human urinary erythropoietin. Journal of Immunological Methods, 113:
261-267.
Morgan M and Maurice S (2007). EPO in cancer anemia: Benefits and potential risks.
Critical Reviews in Oncology/Hematology, 62: 119-125.
N
Neeraj A and Josef TP (2008). Erythropoietic agents and the elderly. Seminars in
Hematology, 45: 267-275.
Ng T, Marz G, Little Wood T and MacDougall I (2003). Recombinant erythropoietin in
clinical practice. Postgraduate Medical Journal, 79: 367-376.
Nicholson BL (1980). Growth of fish cell lines on microcarriers. Applied Environmental
Microbiology, 39: 394–397.
250
Nocka K, Buck J, Levi E and Besmer P (1990). Candidate ligand for the c- kit
transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast
cells and erythroid progenitors. European Molecular Biology Organization Journal, 91:
3287-3294.
P
Pakkanen R and Neutra M (1994). Bovine colostrum ultra filtrate: an effective
supplement of the culture of mouse-mouse hybridoma cells. Journal of Immunological
Methods, 169: 63-71.
Prabhavathy M (2008). Production and process optimization of recombinant human
erythropoietin in serum free medium using recombinant chinese hamster ovary cells.
M.Phil thesis submitted to Acharya Nagarjuna University, Guntur, A.P., India.
Price PJ and Gregory EA (1982). Relationship between in vitro growth promotion and
biophysical and biochemical properties of the serum supplement. In Vitro, 18: 576-584.
R
Rabson AS and Legallais FY (1959). Growth of human epidermoid carcinoma in tissue
culture using non-fat milk medium. Archives of Pathology, 68: 342-347.
Ramirez OT, Sureshkumar GK and Mutharasan R (1990). Bovine colostrums or milk as
a serum substitute for the cultivation of a mouse hybridoma. Biotechnology and
Bioengineering, 35: 882-889.
Rashid SS, Scott WR, Cuiwei L, Janet CC, Kenneth HA, Beisham L, Hangjun Z,
Timothy DO, Arthur JC, Jiandong Z, Janet FM, Steven E, Karen S, Bradley AK, David
JM, John JW, Joan E and Robert M (1998). Efficiency of signaling through cytokine
receptors depends critically on receptor orientation. Stroud Nature, 395: 511-516.
Rauch C, Feifel E, Schoffl H, Pfaller W and Gstraunthaler G (2008). Alternatives to the
use of fetal bovine serum: Platelet lysates as serum replacement in cell and tissue culture.
Alternatives to Laboratory Animals, 25: 54-55.
251
Rauch C, Feifel E, Spotl HP, Amann E, Schennach H, Frank J, Schoffl H, Pfaller W and
Gstraunthaler G (2009). Alternatives to the use of fetal bovine serum: platelet lysates as a
serum substitute in cell culture media. Alternatives to Laboratory Animals, 26: 119.
Reiter M, Bluml G and Zach N (1992). Monoclonal antibody production using the
porous glass bead immobilization technique. serum-free perfusion.
Annals of the New York Academy of Sciences, 665: 146-151.
Risbud MV and Sittinger M (2002). Tissue engineering: advances in in vitro cartilage
generation. Trends in Biotechnology, 20: 351-356.
Robinson CJ (1997). International standards for growth factors and cytokines. Fresenius
Journal of Analytical Chemistry, 360: 476-478.
Ronald MS (1991). Chromatography in enzyme isolation and production, Enzymes in
biomass conversion, ACS publications, Chapter-13, p169-178.
Ross R, Raines EW and Bowen-Pope DF (1986). The biology of platelet-derived growth
factor. Cell, 46: 155-169.
S
Saha SN and Sen AK (1989). Milk whey as a serum supplement for the growth of FMD
virus in BHK-21 cells. Veternary Research Communications, 13: 89-92.
Sandra C, Michael B, Gerard B, John D, Gerhard G, Thomas H, Robert H, Otto-Wilhelm
M, Anna P, Leonard S, Glyn S and William S (2005). Guidance on good cell culture
practice: A report of the second ECVAM task force on good cell culture practice.
Alternatives to Laboratory Animals, 33, 261-268.
Sara PS, Moshe M and Drorit N (2006). Erythropoietin- a hematopoietic hormone with
emerging diverse activities, handbook of biologically active peptides, Chapter-194,
p1393-1400.
Schellekens H and Ryff JC (2002). Biogenerics: the off-patent biotech products. Trends
in Pharmacological Sciences, 23: 119-121.
252
Schrijvers D, Samblanx HD and Roila F (2010). Erythropoiesis-stimulating agents in the
treatment of anaemia in cancer patients: ESMO clinical practice guidelines for use.
Annals of oncology, 21: 244-247.
9.0 Semenza GL (2000). Surviving ischemia: adaptive responses mediated by
hypoxia-inducible factor 1. Journal of Clinical Investigation, 106: 809-812.
Shah G (1999). Why do we still use serum in the production of biopharmaceuticals?.
Developments in Biological Standardization, 99: 17-22.
Shailer C and Corrin K (1999). Serum supply: policies and controls operating in New
Zealand. Developments in Biological Standardization, 99: 71-77.
Shuji T, Masamichi K, Tatsuya O, Masanao O, Shinji I and Takeshi K (1994).
Continuous production of human erythropoietin by immobilized recombinant L-929
cells. Journal of Fermentation and Bioengineering, 77: 52-56.
Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S,
Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H
and Ghezzi P (2000). Erythropoietin prevents neuronal apoptosis after cerebral ischemia
and metabolic stress. Proceedings of National Academy of Sciences (USA), 98: 4044-
4049.
Siren AL, Knerlich F, Poser W, Gleiter CH, Bruck W and Ehrenreich H (2001).
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta
Neuropathologica, 101: 271-276.
Steimer KS and Klagsbrun M (1981). Serum-free growth of normal and transformed
fibroblasts in milk: differential requirements for fibronectin. Journal of Cell Biology, 88:
294-300.
Steimer KS, Packard R, Holden D and Klagsbrun M (1981). The serum-free growth of
cultured cells in bovine colostrums and in milk obtained later in the lactation period.
Journal of Cellular Physiology, 109: 223-234.
253
Steinlein P, Deiner E, Leutz A and Beug H (1994). Recombinant murine erythropoietin
receptor expressed in avian erythroid progenitors mediates terminal erythroid
differentiation in vitro. Growth Factors, 10: 1-16.
Stock UA and Vacanti JP (2001). Tissue engineering: current state and prospects. The
Annual Review of Medicine, 52: 443-451.
Stoll LL and Spector AA (1984). Changes in serum influence the fatty acid composition
of established cell lines. In Vitro, 20: 732-738.
Storring PL and Gaines Das RE (1992). The international standard for recombinant
DNA-derived erythropoietin: collaborative study of four recombinant DNA-derived
erythropoietins and two highly purified human urinary erythropoietins. Journal of
Endocrinology, 134: 3459-3484.
Sun XM and Zhang YX (2001). Effects of glucose on growth, metabolism and EPO
expression in recombinant CHO cell cultures. Chinese Journal of Biotechnology, 17:
698-702.
T
Tabbara IA (1993). Erythropoietin, biology and clinical applications. Archives of
International Medicine, 138: 298-304.
Takeuchi M and Kobata A (1992). Structures and functional roles of the sugar chains of
human erythropoietins. Glycobiology, 1: 337-346.
Taub M (1990). The use of defined media in cell and tissue culture. Toxicology in Vitro,
4: 213-225.
Thomas EW, Keith EF, Geoff CG and John RE (2008). High-speed and high-resolution
UPLC separation at zero degrees celsius. Analytical Chemistry, 80: 6815-6820
Tilbrook PA and Klinken SP (1993). The erythropoietin receptor. International Journal
of Biochemistry and Cell Biology, 31: 1001-1005.
254
Tong EM and Nissenson AR (2001). Erythropoietin and anemia. Seminars in
Nephrology, 21: 190-203.
Tsonis PA (2002). Regenerative biology: the emerging field of tissue repair and
restoration. Differentiation, 70: 397-409.
V
Vadlamudi SK, Stewart WD, Fugate KJ and Tsakeris TM (1991). Performance
characteristics for an immunoassay. Scandinavian Journal of Clinical Laboratory
Investigation, 51: 134-138.
Valent P, Schmidt G, Besemer J, Mayer P, Zenke G, Liehl E, Hinterberger W, Lechner
K, Maurer D and Bettelheim P (1989). Interleukin-3 is a differentiation factor for human
basophils. Blood, 73: 1763-1769.
Vander Valk J, Mellor D, Brands R, Fischer R, Gruber F, Gstraunthaler G, Hellebrekers
L, Hyllner J, Jonker FH, Prieto P, Thalen M and Baumans V (2004). The humane
collection of fetal bovine serum and possibilities for serum-free cell and tissue culture.
Toxicology in vitro, 18: 1-12.
Van Hemert P, Kilburn DG and van Wezel AL (1969). Homogeneous cultivation of
animal cells for the production of virus and virus products. Biotechnology and
Bioengineering, 11: 875–888.
Van Wezel AL (1972). New trends in the preparation of cell substrates for the production
of virus vaccines. Progress in Immunobiological Standardization, 5: 187-192.
Van Wezel AL (1973). Microcarrier cultures of animal cells in tissue culture: Methods
and applications, Academic Press (New York), p372-377.
Vivien MH, Susan R, Terence RL and Peter MA (2007). Pathophysiology of anemia and
erythrocytosis. Critical Reviews in Oncology/Hematology, 64: 139-158.
Vogt C, Pentz S and Rich IN (1989). A role for the macrophage in normal hemopoiesis:
in vitro and in vivo erythropoietin gene expression in macrophages detected by in situ
hybridization. Experimental Hematology, 17: 391-397.
255
W
Wang MD, Yang M, Huzel N and Butler M (2002). Erythropoietin production from
CHO cells grown by continuous culture in a fluidized-bed bioreactor. Biotechnology and
Bioengineering, 77: 194-203.
Wei X, Grill DS, Heatherington AC, Steven J, Swanson A and Shalini G (2007).
Development and validation of a quantitative cell-based bioassay for comparing the
pharmacokinetic profiles of two recombinant erythropoietic proteins in serum. Journal of
Pharmaceutical and Biomedical Analysis, 43: 666-676.
Wen D, Boissel J, Showers M, Ruch BC and Bunn HF (1994). Erythropoietin structure-
function relationships. Journal of Biological Chemistry, 269: 22839-22846.
Werner S and Grose R (2003). Regulation of wound healing by growth factors and
cytokines. Physiological Reviews, 83: 835-870.
Wessman SJ and Levings RL (1999). Benefits and risks due to animal serum used in cell
culture production. Developments in Biological Standardization, 99: 3-8.
Wide L, Bengtsson C and Birgegard G (1989). Circadian rhythm of erythropoietin in
human serum. British Journal of Haematology, 72: 85-90.
Widmann C, Gibson S, Jarpe MB and Johnson GL (1999). Mitogen-activated protein
kinase: conservation of a three-kinase module from yeast to human. Physiological
Reviews, 79: 143-180.
Wojchowski DM, Gregory RC, Miller CP, Pandit AK and Pircher TJ (1999). Signal
transduction in the erythropoietin receptor system. Experimental Cell Research, 253:
143-156.
Y
Yang M and Buttler M (2000). Effects of ammonia on CHO cell growth, erythropoietin
production and glycosylation. Biotechnology and Bioengineering, 68: 370-380.
256
Yoon SK, Choi SL, Song JY and Lee GM (2005). Effect of culture pH on erythropoietin
production by Chinese hamster ovary cells grown in suspension at 32.5 and 37.0oC.
Biotechnology and Bioengineering, 89: 345-356.
9.1 Yoshimura A and Arai K (1996). The erythropoietin receptor and
signal transduction. The Oncologist, 5: 337-339.
Yoshimura A and Misawa H (1998). Physiology and function of the erythropoietin
receptor. Current Opinion in Hematology, 5: 171–176.
Z
Zandstra PW and Nagy A (2001). Stem cell bioengineering. Annual Review of
Biomedical Engineering, 3: 275-305.
257
Web references
9.2 http://www.analyticalventura.com/rp-hplc.shtml, Reverse phase HPLC (last
verified: September 2011).
http://www.antibodyresearch.com/index.php?option=com_myblog&show=serum-free-
media-all-are-not-created-equal.html&Itemid=41, Serum free media: all are not created
equal (last verified: September 2011).
9.3 http://www.athenaes.com/tech_brief_serum_free.php, The case for serum-
free media technical brief (last verified: September 2011).
http://www.bioassay.de/index.php?id=parallel_line_method&L=zhjbsfwpmgbn, The
parallel-line method (last verified: September 2011).
http://www.biochem.uiowa.edu/donelson/Database%20items/protein_purification_handb
ook.pdf, Protein purification handbook (last verified: September 2011).
http://www.biospectrumasia.com/content/130808ind6802.asp, Serum free media: all are
not created equal (last verified: September 2011).
http://www.biotecharticles.com/Others-Article/Three-Phase-Protein-Purification-
strategies-386 .html, Three phase protein purification strategies (last verified: September
2011).
http://www.biotech.kth.se/courses/gru/courselist/BB2040_ENG/ChromMethods.pdf,
Chromatographic methods for protein purification (last verified: September 2011).
http://books.google.com.au/books?id=A76u7g0QnskC, Erythropoietin and the nervous
system (last verified: September 2011).
258
9.4 http://www.caspases.org/showabstract.php?pmid=15469595, Science
Review: recombinant human erythropoietin in critical illness: a role beyond
anemia (last verified: September 2011).
http://chemgroups.northwestern.edu/ohalloran/grouponly/proteinpurification.pdf,
Protein purification handbook (last verified: September 2011).
http://www.ciefforum.com/CEPharm06TechDocs/Comparison%20of%20Different%20M
ethods%20Used%20for%20the%20Determination%20of%20Isoform%20Distribution%
20in%20rHuEPO%20Louise%20Chen%20Amgen%20CEPharm06.pdf, Comparison of
different methods used for the determination of isoform distribution in rHuEPO (last
verified: September 2011).
http://www.dnr-is.com/src/SFM%20General(13).pdf, Introduction to Serum-Free
Medium (last verified: September 2011).
http://dwb.unl.edu/teacher/nsf/c10/c10links/www.emory.edu/INT_MED_REV/Atlanta/pa
per/paper.htm, Regulation of Erythropoiesis (last verified: September 2011).
http://www.gelifesciences.com/aptrix/upp00919.nsf/Content/0E9DAB3298C9C74AC125
7628001CCDD6/$file/18102229AE.pdf, Affinity Chromatography principles and
methods (last verified: September 2011).
http://www.gelifesciences.com/aptrix/upp00919.nsf/Content/226C564DBB7D5229C1257
628001CD36F/$file/18102218AK.pdf, Gel-filtration, principles and methods (last
verified: September 2011).
http://www.gelifesciences.com/aptrix/upp00919.nsf/Content/3E56FFCAFE43BCADC12
57628001D0EC6/$file/11000421AA.pdf, Ion exchange chromatography and
chromatofocusing principles and methods (last verified: September 2011).
http://www.gelifesciences.com/aptrix/upp00919.nsf/Content/861B5EA0F73AB0CBC125
7628001CCFE5/$file/56119098AE.pdf, Sephacryl resin (last verified: September 2011).
http://www.gelifesciences.com/aptrix/upp00919.nsf/content/LD_148896581-B345, Micro
carrier culture- principles and methods (last verified: September 2011).
259
http://www.goodcellculture.com/media/documents/ALTEX27_53_2010.pdf, Serum-free
Cell Culture (last verified: September 2011).
http://www.hematology.org/Publications/50-Years-in-Hematology/4740.aspx, Mile
stones in the study and development of erythropoietin (last verified: September 2011).
http://home.intekom.com/pharm/janssen/eprex.html, Eprex, recombinant human
erythropoietin, Electronic Package Insert (last verified: September 2011).
www.invitrogen.com/etc/medialib/en/filelibrary/pdf.Par.2474.File.dat/Adaptation_CC_S
FM_Y062810_AdatptionOfCell.pdf, Adaptation of cell cultures to a serum-free medium
(last verified: September 2011).
http://www.kejapub.com/ijpbr/docs/IJPBR10-01-04-04.pdf, RP-HPLC Method for the
simultaneous estimation of Lamivudine and Abacavir sulphate in tablet dosage form (last
verified: September 2011).
http://keywen.com/en/GEL_ELECTROPHORESIS, Gel electrophoresis (last verified:
September 2011).
http://www.lifetechindia.com/Attachment_Factors_Tissue_Culture_Life_Technologies_I
ndia.pdf, Attachment factors (last verified: September 2011).
http://www.millipore.com/immunodetection/id3/western_blotting, Western blotting (last
verified: September 2011).
http://www.ncbi.nlm.nih.gov/nuccore/182197?report=fasta Gene Bank: Accession
No.M11319, Sequence of human erythropoietin gene (last verified: September 2011).
http://www.nihs.go.jp/dbcb/Bio-Topic/peptide.pdf, Peptide mapping, purpose and scope,
Stage 5 Proposal global document (last verified: September 2011).
http://www.open.imshealth.com, Biosmilar market (last verified: April 2011).
260
http://www.pall.com/laboratory_42217.asp, Desalting and buffer exchange by dialysis,
gel-filtration, or dia-filtration (last verified: September 2011).
http://www.pall.com/pdf/02.0629_Buffer_Exchange_STR.pdf, Diafiltration: a fast,
efficient method for desalting or buffer exchange of biological samples (last verified:
September 2011).
http://www.pharmainfo.in/jpsr/Documents/Volumes/Vol1Issue3/pdf/jpsr01030912.pdf,
Validated RP-HPLC method for Fluvastin sodium in bulk and its dosage form (last
verified: September 2011).
http://www.piercenet.com/proteomics/browse.cfm?fldID=e9f29426-e119-45f2-9625-
8a5296bf3 e92, Overview of affinity purification (last verified: September 2011).
http://www.promocell.com/fileadmin/promocell/PDF/C-43010.pdf, Cell attachment
factors, promocell instruction manual (last verified: September 2011).
http://www.resintech.com/pdf/EssentialofIonExchange.pdf, Essential of ion exchange
chromatography (last verified: September 2011).
http://www.rofar.org/rainbow/portal/alias__rofar/lang__en-
US/tabID__3353/DesktopDe fault.aspx, Role of GATA transcription factors in
regulating erythropoietin and its receptor in the heart & Study of the characteristics
and fate of erythropoietin-producing cells (last verified: September 2011).
http://rpi.edu/dept/bcbp/molbiochem/MBWeb/mb1/part2/protein.htm, Review: Basic
concepts of protein structure (last verified: September 2011).
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B782W-4B0D1X2-
2V&_u
ser=10&_origUdi=B6VM6-4G4X02N-
CN&_fmt=high&_coverDate=11%2F12%2F2003
261
&_rdoc=1&_orig=article&_origin=article&_zone=related_ref&_acct=C000050221&_
version=1&_urlVersion=0&_userid=10&md5=5756114f19b88c0b40b9b8fb148194f8,
Biochemistry of Erythropoietin (last verified: September 2011).
262
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B782W-4B0D1X2-2W&_
user=10&_origUdi=B6VM6-4G4X02N-
CN&_fmt=high&_coverDate=11%2F12%2F200
3&_rdoc=1&_orig=article&_origin=article&_zone=related_ref&_acct=C000050221_
version=1&_urlVersion=0&_userid=10&md5=51c6a57e31b5320b710ee3c8f0507b06,
Genetics of Erythropoietin (last verified: September 2011).
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B8SV2-4R7VJ06-3GG&
_user=10&_origUdi=B6T98-4S1SJM7-2&_fmt=high&_coverDate=01%2F10%2F2011
&_rdoc=1&_orig=article&_origin=article&_zone=related_ref&_acct=C000050221&_
version=1&_urlVersion=0&_userid=10&md5=989b28ed16e981e2e6cb1354daa3c1ce,
Erythropoiesis (last verified: September 2011).
http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/General_Information/vol5-
issue3-cell-culture.Par.0001.File.tmp/vol5-issue3-cell-culture.pdf, Medium optimization
kit for CHO cells: using factorial matrix design of experiment to increase cell
performance (last verified: September 2011).
http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/Product_Information_Sheet/1/q1
126pis.Par.0001.File.tmp/q1126pis.pdf, Sepharose-Based ion exchange Media (last
verified: September 2011).
http://www.sigmaaldrich.com/etc/medialib/flashapps/biofiles-movie/pdf/biofiles-issue3-
8.Par.0001.File.dat/biofiles_issue3.8.pdf, Attachment and matrix factors (last verified:
September 2011).
http://www.sigmaaldrich.com/life-science/cell-culture/serum-free-media/protein-expressi
ion-cho.html, CHO platform (last verified: September 2011).
http://www.sigmaaldrich.com/life-science/proteomics/protein-electrophoresis/western-
blo
tting/membranes-blotting-paper.html, Membranes blotting paper (last verified:
September 2011).
263
http://www.slideshare.net/guest303321/protein-purification-handbook-1521328, Protein
purification handbook (last verified: September 2011).
http://www.son.washington.edu/research/internal/Labs/molecular/Mol04.doc, SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) (last verified: September 2011).
http://www.steroidreport.com/2008/07/21/biosimilar-epo-agents, Use of biosimilar EPO
agents widespread at 2008, Steroid report (last verified: September 2011).
http://www.tititudorancea.com/z/erythropoietin.htm, Erythropoietin (last verified:
September 2011).
http://www.ucl.ac.uk/~ucbcdab/enzpur/ionX.htm, Principle of ion exchange
chromatography (last verified: September 2011).